Archives
-
WWP2–DDX3X Control of Diabetic Endothelial Injury
2026-09-18
You et al. identify endothelial WWP2 as a protective regulator of Type 2 diabetes mellitus-associated vascular injury and connect its loss to impaired DDX3X turnover. By combining patient single-cell data, endothelial-specific knockout mice, cultured endothelial cells, and ubiquitination assays, the study defines a JNK–WWP2–DDX3X axis with implications for diabetic vascular complication research.
-
Caspase-3/7 Inhibitor I: Apoptosis Workflows
2026-09-17
Build cleaner apoptosis experiments with a reversible, cell-permeable inhibitor that separates executioner-caspase activity from upstream stress signaling. This guide applies the compound to Jurkat apoptosis assays and to mechanistic studies inspired by Candida krusei injury in bovine mammary epithelial cells.
-
α-Linolenic Acid: From Lipid Substrate to Signal
2026-09-17
α-Linolenic Acid is more than an essential omega-3 input: it is a tractable substrate for studying lipid fate, signaling, cardiovascular physiology, inflammation, and cancer biology. This translational guide connects ALA workflow design with recent evidence that dietary polyunsaturated fatty acids can shape immune outcomes, while maintaining a clear boundary between mechanistic opportunity and clinical evidence.
-
Lysis Buffer for Rapid Mouse Genotyping
2026-09-16
Turn small tail, toe, or ear samples into PCR-ready genomic DNA with a workflow designed for speed, consistency, and minimal handling. This guide connects practical mouse genotyping with model-validation needs in translational cancer research while separating proven product features from optimization recommendations.
-
Pronase E for Proteomics and Protein Digestion
2026-09-16
Pronase E is a broad-spectrum protease mixture for controlled protein sample preparation, peptide mapping, and target-engagement workflows. This guide translates ferroptosis research into practical digestion strategies while emphasizing optimization, comparators, and safeguards against over-digestion.
-
SB-3CT Workflows for MMP-2/MMP-9 Research
2026-09-15
SB-3CT is a mechanism-based gelatinase inhibitor for dissecting MMP-2 and MMP-9 activity in extracellular-matrix remodeling. This practical guide connects biochemical assays with tumor metastasis research, perineuronal-net studies, and neuroprotection in cerebral ischemia while emphasizing exposure control and interpretation limits.
-
Inducing Right Ventricular-Like Cardiomyocytes
2026-09-15
Saito et al. developed a differentiation strategy that shifts human pluripotent stem cell cardiac progenitors toward an anterior second heart field-like identity and produces right ventricular-like cardiomyocytes. By modulating BMP signaling during mesoderm formation, the study generated cells with chamber-associated gene-expression and functional differences that may improve right-sided heart disease modeling.
-
Piezo1, Matrix Stiffness, and DRG Axon Regeneration
2026-09-14
The reference study identifies a stiffness-sensitive Piezo1–Ca2+–CaMKII–FAK–actin pathway that controls dorsal root ganglion axon regrowth. Its most notable finding is that Piezo1 knockdown can improve adult sciatic nerve regeneration, highlighting mechanical microenvironment tuning as a context-dependent repair strategy.
-
Pronase E: Translating Ferroptosis Mechanism
2026-09-14
A translational strategy for using Pronase E as a broad-spectrum protease mixture in proteomic workflows investigating gramine, the CUL3–MTDH axis, and ferroptosis in triple-negative breast cancer.
-
Calpain Inhibitor II, ALLM for Protease Research
2026-09-13
Calpain Inhibitor II, ALLM is a cell-permeable, broad cysteine-protease tool for connecting calpain and cathepsin activity with apoptosis, FAK stability, and tumor-cell behavior. Its strongest use is comparative pathway testing: combine dose-response studies with cleavage, viability, and rescue assays rather than interpreting cytotoxicity as calpain-2-specific evidence.
-
TCEP Hydrochloride and Smarter LFA Sensitivity
2026-09-12
A translational analysis of how TCEP hydrochloride could support disulfide-triggered capture-and-release architectures in lateral flow assays, with emphasis on mechanism, assay compatibility, evidence boundaries, and practical development strategy.
-
Elbasvir–Grazoprevir: Evidence for HCV Treatment
2026-09-11
This literature-focused review examines how complementary NS5A and NS3/4A inhibition underpins elbasvir–grazoprevir therapy for chronic hepatitis C. The reference paper integrates pharmacology, pharmacokinetics, clinical efficacy, resistance, safety, and special-population evidence, with particularly strong support for HCV genotype 1 and 4 infections.
-
ONX-0914 (PR-957) Workflow for Immune Studies
2026-09-11
ONX-0914 (PR-957) provides a selective way to interrogate LMP7-driven immune signaling without treating the constitutive β5 proteasome as the primary target. This article translates new extracellular-vesicle findings into practical cytokine, cell-transfer, arthritis research, and diabetes research workflows, with optimization points for compound handling and assay interpretation.
-
Lopinavir: From HIV Protease to Translational Strategy
2026-09-10
Lopinavir (ABT-378) illustrates how mechanism-led compound selection can connect HIV protease biology with broader antiviral discovery. This article examines its resistance-aware potency, serum-context behavior, assay design considerations, pharmacokinetic implications, and the limits of interpreting cross-pathogen cell-culture findings.
-
Thrombin B Chain Fragment: Assay Workflow Guide
2026-09-10
Use this defined human thrombin B-chain peptide as a sequence-controlled reagent for binding, mass-spectrometry, and fibrin-related assay development—not as an assumed replacement for intact catalytic thrombin. The workflow combines careful reconstitution, matched controls, orthogonal readouts, and reference-study principles for distinguishing genuine protease effects from nonspecific assay artifacts.